Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Endris

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Der Pathologe|August 10, 2014
[Molecular pathology of lung cancer. State of the art 2014]A Warth, V Endris, R Penzel, et al.
Deutsche Medizinische Wochenschrift (1946)|May 15, 2013
[Molecular diagnostics in pathology]A Stenzinger, R Penzel, V Endris, et al.
Cancer Genetics and Cytogenetics|February 15, 2001
Comparison of the malignant phenotype and genotype of the human androgen-independent cell line DU 145 and a subline derived from metastasis after orthotopic implantation in nude miceA Bex, B Wullich, V Endris, et al.
Der Pathologe|March 31, 2015
[Molecular diagnostics of non-small cell lung cancer: New markers and technologies]A Warth, V Endris, M Kriegsmann, et al.
Journal of Medical Genetics|December 14, 2004
Position effect on PLP1 may cause a subset of Pelizaeus-Merzbacher disease symptomsN Muncke, B S Wogatzky, M Breuning, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
PARP inhibition in BRCA2-mutated prostate cancerC Nientiedt, Y Tolstov, A-L Volckmar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2016
Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiationI Tinhofer, A Stenzinger, T Eder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2019
Optimizing panel-based tumor mutational burden (TMB) measurementJ Budczies, M Allgäuer, K Litchfield, et al.
Der Pathologe|May 16, 2019
[From panel diagnostics to comprehensive genomic analysis : Infobesity or empowerment?]J Leichsenring, D Kazdal, C Ploeger, et al.
Oncogenesis|May 16, 2017
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activationJ Xu, N Pfarr, V Endris, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Der Pathologe|August 10, 2014
[Molecular pathology of lung cancer. State of the art 2014]A Warth, V Endris, R Penzel, et al.
Deutsche Medizinische Wochenschrift (1946)|May 15, 2013
[Molecular diagnostics in pathology]A Stenzinger, R Penzel, V Endris, et al.
Cancer Genetics and Cytogenetics|February 15, 2001
Comparison of the malignant phenotype and genotype of the human androgen-independent cell line DU 145 and a subline derived from metastasis after orthotopic implantation in nude miceA Bex, B Wullich, V Endris, et al.
Der Pathologe|March 31, 2015
[Molecular diagnostics of non-small cell lung cancer: New markers and technologies]A Warth, V Endris, M Kriegsmann, et al.
Journal of Medical Genetics|December 14, 2004
Position effect on PLP1 may cause a subset of Pelizaeus-Merzbacher disease symptomsN Muncke, B S Wogatzky, M Breuning, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
PARP inhibition in BRCA2-mutated prostate cancerC Nientiedt, Y Tolstov, A-L Volckmar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2016
Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiationI Tinhofer, A Stenzinger, T Eder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2019
Optimizing panel-based tumor mutational burden (TMB) measurementJ Budczies, M Allgäuer, K Litchfield, et al.
Der Pathologe|May 16, 2019
[From panel diagnostics to comprehensive genomic analysis : Infobesity or empowerment?]J Leichsenring, D Kazdal, C Ploeger, et al.
Oncogenesis|May 16, 2017
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activationJ Xu, N Pfarr, V Endris, et al.
Pageof 2